At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
Choroidal thickness measurements with SD-OCT deviceother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Choroidal Thickness Using Spectral Optical Coherence Tomography in Pseudoexfoliation Glaucoma and Primary Open Angle Glaucoma
In Brief
An observational study evaluating Choroidal thickness measurements with SD-OCT device for Glaucoma, Open-Angle. Completed, enrolled 90 participants.
Detailed Summary
Purpose: To investigate the effect of pseudoexfoliation (PEX) on choroidal thickness in primary open-angle glaucoma (POAG). Methods: This prospective, randomized study included 30 POAG patients and 30 PEX glaucoma patients with similar demographic characteristics, and 30 eyes of 30 healthy individuals comprised the control group. Macular choroidal thickness was measured using a Cirrus HD spectral domain optical coherence tomography (OCT) instrument.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Open-Angle
Countries--
CollaboratorsIzmir Ataturk Training and Research Hospital
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
Primary CompletionFeb 2015
Study CompletionAug 2015
First PostedDec 2017
TodayJul 2026
First PostedDec 14, 2017
Enrollment StartAug 15, 2014
Primary CompletionFeb 15, 2015
Study CompletionAug 15, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.5 years ago
Interventions
Choroidal thickness measurements with SD-OCT deviceother